CVS Health price target raised to $74 from $58 at RBC Capital
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform rating on the ...
CVS Health price target raised to $70 from $66 at Deutsche Bank
Deutsche Bank raised the firm’s price target on CVS Health (CVS) to $70 from $66 and keeps a Buy rating on the shares. The company issued a ...
CVS wins upgrade to buy as analyst sees more upside potential than its peers
A Leerink analyst says CVS is starting to benefit from stabilization in its Aetna health-insurance and pharmacy-benefits ...
News Medical2d
Top California democrats clash over how to rein in drug industry middlemen
California Gov. Gavin Newsom and state legislators in Sacramento seem to agree: Prescription drug prices are too high.
CVS Health (CVS) Q4 2024 Earnings Call Transcript
Operator Good morning, and thank you all for attending the CVS Health Q4 2024 earnings conference call. My name is Brika, and I will be your moderator for today's call. [Operator instructions] I would ...